dihydroergocornine has been researched along with dihydroergotamine in 4 studies
| Studies (dihydroergocornine) | Trials (dihydroergocornine) | Recent Studies (post-2010) (dihydroergocornine) | Studies (dihydroergotamine) | Trials (dihydroergotamine) | Recent Studies (post-2010) (dihydroergotamine) |
|---|---|---|---|---|---|
| 32 | 1 | 1 | 1,450 | 241 | 116 |
| Protein | Taxonomy | dihydroergocornine (IC50) | dihydroergotamine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.09 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 3.9996 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.001 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0089 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0039 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.01 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0007 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 2.395 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.029 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.008 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.09 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0007 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0053 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0068 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.0032 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LAGERLOF, H; WERKO, L | 1 |
| ORTH, OS | 1 |
| BENNETT, WD; DHUNER, KG; ORTH, OS | 1 |
| BLUNTSCHILI, JH; GOETZ, RH | 1 |
4 other study(ies) available for dihydroergocornine and dihydroergotamine
| Article | Year |
|---|---|
The effect of dihydroergotamine and dihydroergocornine on cardiac output and blood pressure in hypertension.
Topics: Blood Pressure; Cardiac Output; Claviceps; Dihydroergocornine; Dihydroergotamine; Ergot Alkaloids; Heart; Hypertension | 1949 |
The use of dihydroergotamine (D.H.E. 45) and dihydroergocornine (D.H.O. 180) to prevent cardiac irregularities during cyclopropane anesthesia.
Topics: Anesthesia; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cyclopropanes; Dihydroergocornine; Dihydroergotamine; Heart Conduction System; Humans | 1949 |
A comparison of the effectiveness of dihydroergotamine (DHE-45) and dihydroergocornine (DHO-180) in the prevention of cardiac irregularities during cyclopropane anesthesia.
Topics: Anesthesia; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cyclopropanes; Dihydroergocornine; Dihydroergotamine; Heart Conduction System; Heart Rate; Humans | 1949 |
The effect of ergot derivatives on the circulation in man with special reference to two new hydrogenated compounds, dihydroergotamine and dihydroergocornine.
Topics: Dihydroergocornine; Dihydroergotamine; Ergot Alkaloids; Humans | 1948 |